Compare Cytokinetics Inc (CYTK) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Ryanair Holdings plc — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Ryanair Holdings plc trades at $60.03 (market cap $29.63B). The key difference: Ryanair Holdings plc is far larger — about 2.8× Cytokinetics Inc's market cap, and Ryanair Holdings plc pays a 1.51% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | RYAAY | |
|---|---|---|
Market Cap | $10.63B | $29.63B |
Sector | Technology | Industrials |
52-Week High | $87.26 | $73.82 |
52-Week Low | $34.31 | $53.24 |
Enterprise Value | $10.74B | $26.61B |
Dividend Yield | — | 1.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
